Health

Phase-3 Trial For Dengue Vaccine Soon: ICMR

By
OB Bureau

New Delhi: Phase-3 trial for a dengue vaccine developed by Panacea Biotech is likely to begin in a few months. The vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR), news agency ANI reported quoting an official.

The phase-3 trial is a randomised, double-blind, placebo-controlled trial. This means that participants are randomly assigned to receive either the vaccine or a placebo. Neither the participants nor the investigators will know who is receiving the vaccine and who is receiving the placebo.

“The trials are underway but they have not yet fully started because we are waiting for the company to make the product which could not be made three months ago. The company should be ready in August. So, those phase-3 trials should be initiated in a few months,” said Dr Rajiv Bahl, director general of ICMR, as quoted by news agency ANI.

The primary goal of the trial is to assess the efficacy of the vaccine in preventing dengue fever. The secondary endpoints of the trial will examine the safety of the vaccine. Dr Nivedita Gupta, head of ICMR’s communicable diseases department was quoted as saying that Panacea Biotech has already completed the phase-1/2 trials of the vaccine on healthy adults in India.

“We have some preliminary immunogenicity results also. So all the paperwork has been done and the approval for phase-3 randomised double-blind, placebo controlled trial from the Drugs Controller General of India (DCGI) has also been obtained in January. The trial will be conducted on 10,335 healthy adults aged 18-80 years at 20 sites,” Dr Gupta said as quoted by news agency PTI.

 

OB Bureau

Recent Posts

Man Stabs Brother-In-Law To Death In Odisha’s Sundargarh

Sundargarh: Police arrested a man for allegedly killing his brother-in-law for torturing his sister in…

March 28, 2024

Heavyweight Collaboration: In A First, Reliance Picks Up 26% Stake In Adani Power Project

Mumbai: This is what you call a heavyweight collaboration. In a first-of-its-kind collaboration between rival…

March 28, 2024

PDS Queues Longer, Market Price Of Rice Higher As Kashmir Ditches Paddy For Apple Crop, Urbanisation

Mohammad Aatif Ammad Kanth Anantnag (Jammu & Kashmir): On a chilly winter morning, Irshad Bhat…

March 28, 2024

Odisha Polls: Former Chitrakonda MLA Dambaru Sisa Resigns From BJD

Bhubaneswar: The former MLA of BJD from Chitrakonda in Odisha's Malkangiri district, Dambaru Sisa, on…

March 28, 2024

LS Polls: JMM Nominates Anjani Soren For Odisha’s Mayurbhanj Seat

Bhubaneswar: The Jharkhand Mukti Morcha (JMM) has announced Anjani Soren as its candidate for Lok…

March 28, 2024

IESA Signs MoU With Bhubaneswar’s BCKIC To Work In Critical Minerals & Energy Sector

Bhubaneswar: India Energy Storage Alliance (IESA) signed a Memorandum of Understanding with Bhubaneswar City Knowledge…

March 28, 2024

Vigilance Nabs OSD In Odisha’s Nuapada Collectorate While Taking Bribe Of Rs 30,000

Bhubaneswar: Odisha Vigilance on Thursday apprehended an officer in the collectorate of Nuapada district while…

March 28, 2024

Odisha Javelin Star Kishore Jena Set For Diamond League Debut; Neeraj Chopra Among Strong Field

Bhubaneswar: Odisha’s star javelin thrower Kishore Jena had a stellar season in 2023. And he’s…

March 28, 2024